Blinatumomab
Catalogue number:
HY-P9963-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
CD19
Alternative Names:
Anatumomab; bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia[1][2][3][4].